Analyst Ratings For Tetraphase Pharmaceuticals (NASDAQ:TTPH)
Today, Tetraphase Pharmaceuticals (NASDAQ:TTPH) stock received an upgrade by Stifel Nicolaus from Hold to Buy with a price target of $15.00.
There are 1 hold rating, 3 buy ratings on the stock.
The current consensus rating on Tetraphase Pharmaceuticals (NASDAQ:TTPH) is Buy (Score: 2.75) with a consensus target price of $11.50 per share, a potential 66.67% upside.
Some recent analyst ratings include
- 7/26/2017-Stifel Nicolaus Upgrade from a “Hold ” rating to a ” Buy” rating.
- 7/11/2017-HC Wainwright initiated coverage with a Buy rating.
- 5/15/2017-BMO Capital Markets Reiterated Rating of Buy.
- 11/4/2016-Wedbush Reiterated Rating of Neutral.
- 5/16/2016-Gabelli Reiterated Rating of Neutral.
- 5/14/2016-Needham & Company LLC Reiterated Rating of Hold.
- 11/19/2015-SunTrust Banks, Inc. Upgrade from a “Neutral ” rating to a ” Buy” rating.
Recent Insider Trading Activity For Tetraphase Pharmaceuticals (NASDAQ:TTPH)
Tetraphase Pharmaceuticals (NASDAQ:TTPH) has insider ownership of 5.50% and institutional ownership of 46.24%.
- On 3/15/2017 L Patrick Gage, Director, bought 11,000 with an average share price of $7.49 per share and the total transaction amounting to $82,390.00. View SEC Filing
- On 9/1/2015 Guy Macdonald, insider, sold 10,000 with an average share price of $41.57 per share and the total transaction amounting to $415,700.00. View SEC Filing
- On 8/14/2015 David Charles Lubner, CFO, sold 9,500 with an average share price of $42.92 per share and the total transaction amounting to $407,740.00. View SEC Filing
- On 8/13/2015 Patrick Taylor Horn, Insider, sold 10,000 with an average share price of $44.69 per share and the total transaction amounting to $446,900.00. View SEC Filing
- On 8/12/2015 L Patrick Gage, Director, sold 15,000 with an average share price of $45.00 per share and the total transaction amounting to $675,000.00. View SEC Filing
- On 7/20/2015 Guy Macdonald, Insider, sold 15,000 with an average share price of $50.72 per share and the total transaction amounting to $760,800.00. View SEC Filing
- On 7/14/2015 David Charles Lubner, CFO, sold 7,500 with an average share price of $48.92 per share and the total transaction amounting to $366,900.00. View SEC Filing
Recent Trading Activity for Tetraphase Pharmaceuticals (NASDAQ:TTPH)
Shares of Tetraphase Pharmaceuticals closed the previous trading session at 6.90 down -0.40 -5.48% with 1,261,161 shares trading hands.